Further, in cultured mouse and human islets, testosterone also amplifies the insulinotropic effect of exogenous GLP-1. It also suggests that testosterone amplifies the insulinotropic effect of islet-derived GLP-1 in vivo. For that reason, we explored the possibility that AR action in β-cells amplifies GLP-1R signaling to increase cAMP production. Interestingly, in β-cells, AR exhibits a predominant extranuclear location and remains extranuclear following ligand stimulation. In classical androgen-sensitive tissues, AR is a ligand-activated nuclear receptor that regulates gene expression through binding to an androgen response element on the promoter of target genes (Chang et al., 1988, Lubahn et al., 1988, Tilley et al., 1989).
Given the decline in androgen levels with aging that has been documented in epidemiological studies, it was postulated that some features of aging such as frailty and loss of vigor could be attributed to androgen deficiency. We concluded that the relationship between testosterone and insulin resistance in men is bidirectional. We also showed that weight loss can increase testosterone levels and reverse hypogonadism in over 50% of obese men with impaired glucose tolerance. Using functional and genetic studies, we provided evidence that hypogonadism may induce insulin resistance by causing mitochondrial dysfunction. While your body normally carefully balances its hormones, having too little or too much of a certain hormone can lead to health problems. An endocrinologist is a healthcare provider who specializes in endocrinology, a field of medicine that studies conditions related to your hormones..|The normal aging process is accompanied by physiological changes in target organs that are sites of androgen action. However, the approval of a transdermal testosterone delivery system in the form of a gel meant that testosterone could now be administered easily, conveniently, and in a pain-free manner (3). For decades, the only method of delivering testosterone was through a deep, painful intramuscular injection every two weeks. A second important factor that contributed to the more widespread use of testosterone was the development of more patient-friendly formulations. While increasing awareness of and demand for a medication may be beneficial if the risk-benefit ratio of the drug is favorable, that assumption is questionable for many men taking testosterone for nonspecific symptoms without a clear diagnosis. When prescribing trends are compared between countries, it is evident that this increase in testosterone use was most marked in the United States, with relatively little change in the United Kingdom (1).|Shaded area represents values for subjects with hypogonadal testosterone levels (i.e., 2 max) (C) and expression of UQCRB in skeletal muscle (D). Correlation between insulin sensitivity (M) and serum testosterone (T) levels (A) and SHBG levels (B) in 60 men; 27 had NGT (□), 12 had IGT (△), and 21 had type 2 diabetes (•). In terms of addressing causality, it has been shown that improving insulin sensitivity by losing weight, whether by lifestyle changes or bariatric surgery, results in a significant increase in total testosterone levels (17). We and others have shown that testosterone levels are significantly lower in men with impaired glucose tolerance and T2DM than in normoglycemic controls (16). Men with hypogonadal testosterone levels were twice as insulin resistant as eugonadal controls. Given that low testosterone levels predict type 2 diabetes mellitus (T2DM) in men, we sought to dissect the relationship between testosterone and insulin sensitivity in men.|Myo-inositol also improves peripheral insulin sensitivity by enhancing the activity of insulin receptor substrate-1 (IRS-1) pathways. Additionally, hyperglycemia-induced inflammation further deteriorates β cell function in women with PCOS (Malin et al., 2015). First, acute testosterone exposure produces insulin hypersecretion in an AR-dependent manner in cultured female mouse and human islets incubated in high glucose. To explore this hypothesis, we generated female mice with testosterone excess and conditional AR deletion in β-cells (βARKO) (Navarro et al., 2018).}
Despite evidences indicate a close relationship between testosterone and glucose metabolism, the molecular mechanisms responsible for a possible testosterone-mediated insulin-like effects on skeletal muscle are still unknown. In addition to adult androgen excess, developmental androgen excess in female mammal fetuses programs female β cells in utero via AR (Mauvais-Jarvis, 2016). Together, these studies suggest that, in the presence of prior or additional islet metabolic stress, the deleterious effect of chronic AR activation by testosterone causes β cell hyperfunction, oxidative stress, and mitochondrial dysfunction, which predisposes to secondary β cell demise in female mice. Female mice exposed to chronic testosterone excess become more susceptible to additional islet oxidative stress induced by either a Western diet or streptozotocin, in a manner dependent on AR in β cells (Navarro et al., 2018). Second, testosterone enhances mitochondrial respiration and oxygen consumption in female mouse cultured islets, and accordingly, chronic testosterone excess in vivo produces islet oxidative injury via AR in β cells. However, they also developed secondary β cell failure due to a failed attempt at compensation for insulin resistance, leading to hyperglycemia in the fasting and fed state and during a glucose challenge. Obviously, the design of SARMs with AR agonistic action in β cells represents a therapeutic avenue to prevent androgen deficiency-related diabetes in men.
Therefore, a model is emerging in which testosterone provides fine-tuning of insulin secretion in males by enhancing the β cell insulinotropic actions of GLP-1 (Fig.1). This led to the discovery that the insulinotropic effect of testosterone via AR in islets β-cells is dependent on activation of the GLP-1 receptor (GLP-1R) by islet-derived GLP-1, as it is abolished in the presence of a GLP-1R antagonist (Navarro et al., 2016). This observation suggests that the insulinotropic effect of testosterone requires a secreted factor, produced by islet non-β-cells and acting on β-cells, to facilitate the effect of testosterone in a paracrine manner. Interestingly, the insulinotropic effect of testosterone alone observed in mouse and human islets is not observed in insulin-secreting INS-1 cells, even though these cells express AR. To explore this possibility using animal models, we generated mice with selective AR depletion in pancreatic β cells (βARKO) (Navarro et al., 2016). Taken together, these observations suggest that testosterone deficiency, such as that observed during ADT, predisposes to β cell dysfunction and failure in men, and that testosterone may improve insulin secretion in these subjects. In another study performed in obese men with secondary hypogonadism, testosterone therapy improved β cell function (HOMA %B) and glycemic control (Dimitriadis et al., 2018).
However, although it is established that hyperglycemia requires β cell dysfunction to develop, the role of testosterone in β cell function is less understood. Severe testosterone deficiency predisposes men to type 2 diabetes (T2D), while in contrast, androgen excess predisposes women to hyperglycemia. One of the most sexually dimorphic aspects of metabolic regulation is the bidirectional modulation of glucose homeostasis by testosterone in male and females. Positive correlation between insulin sensitivity (M) and increase in testosterone post stimulation of… Our data also suggest that testosterone may affect insulin sensitivity both directly and indirectly.
Importantly, neither insulin resistance nor visceral adiposity can induce hyperglycemia without β cell failure to compensate for the insulin resistance (1995, Weyer et al., 1999, Polonsky, 1995, Prentki and Nolan, 2006). In contrast, and surprisingly, the role of testosterone deficiency in predisposing to pancreatic β cell dysfunction and therefore insulin deficiency remains ignored. The metabolic effect of testosterone deficiency in promoting visceral obesity and impairing insulin sensitivity in men is well established (Navarro et al., 2015, Zitzmann, 2009). Prostate cancer is the most common cancer in men, and androgen deprivation therapy (ADT), the standard of treatment, promotes severe testosterone deficiency and predisposes to metabolic complications (Faris and Smith, 2010, Navarro et al., 2015, Zitzmann, 2009). Although it is established that β cell dysfunction is necessary for hyperglycemia to develop, the role of testosterone in β cell function and insulin secretion is poorly understood. The role of androgen deficiency and excess in promoting visceral obesity and insulin resistance in men and women respectively is well established. Correlation between insulin sensitivity (M) and serum testosterone (T) levels (A) and SHBG…
In the Massachusetts Male Aging Study, a population-based prospective study that followed over a thousand men aged for almost 10 years, the authors reported that low serum testosterone concentrations play a role in the development of T2D (Stellato et al., 2000). This effect was subsequently overshadowed by profound changes in body composition that occurred 9 months postoperatively and led to the development of overt diabetes. Luteinizing hormone and follicle-stimulating hormone were low preoperatively and increased postoperatively, reaching values close to the postmenopausal normal range after 9 months, possibly due to a slow recovery of the gonadotrophs from the 10-year suppression by testosterone. Dehydroepiandrosterone-S and 17-OH-progesterone were low before and after surgery, suggesting a normal adrenal androgen production.
The effects of T onto I-related signal transduction pathways were investigated in undifferentiated Hfsmc cells treated with T for 15 min, 30 min, 2, 6 and 12 h vs. T0 (time before stimuli addition); 15 min I treatment was used as positive control. T insulin-like effects on human skeletal muscle cells has been not yet fully investigated. We know that acute physical exercise induces a rapid increase in the human serum endogenous levels of several circulating factors such as T 4–6, but the related short-term effects on T-targeted cells, such as skeletal muscle cells, have been not yet characterized. All together our data indicate that testosterone through the activation of non-genomic pathways, participates in skeletal muscle glucose metabolism by inducing insulin-related effects. GLUT4 cell expression, localization and the phosphorylation/activation of AKT, ERK, mTOR and GSK3β insulin-related pathways at different time points after treatment with testosterone were analyzed.

Gender: Female

Social links